Stock Events

Stock Events

Spectral Medical 

€0.85
10
-€0.02-1.74% Wednesday 06:04

Statistics

Day High
0.86
Day Low
0.86
52W High
1.11
52W Low
0.43
Volume
-
Avg. Volume
-
Mkt Cap
241.41M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jan 12
€0.09
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

8MayExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.11
-0.07
-0.04
0
Expected EPS
-0.009976309056
Actual EPS
N/A

Financials

-672.43%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
3.08MRevenue
-20.71MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SD4.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cytodyn
CYDY
Mkt Cap302.34M
CytoDyn Inc. focuses on innovative treatments for critical care, which includes sepsis and acute respiratory distress syndrome, areas Spectral Medical is also involved in.
Mesoblast
MESO
Mkt Cap2.14B
Mesoblast Limited specializes in regenerative medicine, including therapies for inflammatory ailments, directly competing with Spectral's treatments for critical care conditions.
Protalix BioTherapeutics
PLX
Mkt Cap188.97M
Protalix BioTherapeutics, Inc. engages in biopharmaceuticals targeting rare diseases, some of which may overlap with Spectral Medical's target conditions.
Mimedx Group
MDXG
Mkt Cap1.13B
MiMedx Group, Inc. offers regenerative biomaterials for inflammation management, competing in the broader market of critical care and regenerative medicine.
Adma Biologics
ADMA
Mkt Cap3.69B
ADMA Biologics, Inc. focuses on the development and commercialization of human plasma and plasma-derived therapeutics, including for immune disorders, potentially competing in Spectral's market.

About

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Christopher Seto
Employees
29
Country
CA
ISIN
CA8475771033
WKN
000A12HJ9

Listings

OTC Link
US
EDTXF
TO
CA
EDT.TO
F
DE
SD4.F

0 Comments

Share your thoughts

FAQ

What is Spectral Medical stock price today?▼
The current price of SD4.F is €0.85 EUR — it has decreased by -1.74% in the past 24 hours. Watch Spectral Medical stock price performance more closely on the chart.
What is Spectral Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Spectral Medical stocks are traded under the ticker SD4.F.
Is Spectral Medical stock price growing?▼
SD4.F stock has fallen by -6.11% compared to the previous week, the month change is a +5.62% rise, over the last year Spectral Medical has showed a +73.16% increase.
What is Spectral Medical market cap?▼
Today Spectral Medical has the market capitalization of 241.41M
When is the next Spectral Medical earnings date?▼
Spectral Medical is going to release the next earnings report on May 08, 2026.
What were Spectral Medical earnings last quarter?▼
SD4.F earnings for the last quarter are -0.07 EUR per share, whereas the estimation was -0.01 EUR resulting in a -1,000% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Spectral Medical revenue for the last year?▼
Spectral Medical revenue for the last year amounts to 3.08M EUR.
What is Spectral Medical net income for the last year?▼
SD4.F net income for the last year is -20.71M EUR.
Does Spectral Medical pay dividends?▼
Yes, SD4.F dividends are paid semi-annual. The last dividend per share was 0.09 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Spectral Medical have?▼
As of April 02, 2026, the company has 29 employees.
In which sector is Spectral Medical located?▼
Spectral Medical operates in the Health Care sector.
When did Spectral Medical complete a stock split?▼
Spectral Medical has not had any recent stock splits.
Where is Spectral Medical headquartered?▼
Spectral Medical is headquartered in Toronto, CA.